State Street’s Compugen CGEN Stock Holding History

State Street’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$890K	Buy	415,668 +302	+0.1%	+$757	﹤0.01%	3481
2026 Q1	$885K	Buy	415,366 +21,564	+5%	+$41.9K	﹤0.01%	3516
2025 Q4	$603K	Buy	393,802 +14,701	+4%	+$24.4K	﹤0.01%	3631
2025 Q3	$557K	Buy	379,101 +27,922	+8%	+$41.5K	﹤0.01%	3638
2025 Q2	$625K	Buy	351,179 +7,046	+2%	+$10.4K	﹤0.01%	3577
2025 Q1	$502K	Buy	344,133 +175,457	+104%	+$343K	﹤0.01%	3587
2024 Q4	$258K	Buy	168,676 +1,569	+0.9%	+$2.55K	﹤0.01%	3786
2024 Q3	$302K	Buy	167,107 +2,370	+1%	+$4.33K	﹤0.01%	3712
2024 Q2	$277K	Buy	164,737 +2,679	+2%	+$5.58K	﹤0.01%	3729
2024 Q1	$418K	Sell	162,058 -2,979	-2%	-$6.94K	﹤0.01%	3697
2023 Q4	$327K	Buy	165,037 +2,755	+2%	+$2.41K	﹤0.01%	3754
2023 Q3	$151K	Buy	162,282 +3,591	+2%	+$3.95K	﹤0.01%	4006
2023 Q2	$181K	Buy	158,691 +2,923	+2%	+$2.55K	﹤0.01%	4036
2023 Q1	$109K	Buy	155,768 +6,639	+4%	+$5.46K	﹤0.01%	4300
2022 Q4	$107K	Buy	149,129 +9,110	+7%	+$7.95K	﹤0.01%	4350
2022 Q3	$92K	Buy	140,019 +2,677	+2%	+$3.78K	﹤0.01%	4489
2022 Q2	$254K	Sell	137,342 -615,168	-82%	-$1.33M	﹤0.01%	4098
2022 Q1	$2.42M	Buy	752,510 +68,338	+10%	+$231K	﹤0.01%	3492
2021 Q4	$2.94M	Sell	684,172 -1	-0%	-$5	﹤0.01%	3498
2021 Q3	$4.08M	Buy	684,173 +28,777	+4%	+$193K	﹤0.01%	3337
2021 Q2	$5.43M	Buy	655,396 +73,010	+13%	+$593K	﹤0.01%	3205
2021 Q1	$5M	Buy	582,386 +19,600	+3%	+$217K	﹤0.01%	3052
2020 Q4	$6.82M	Buy	562,786 +57,556	+11%	+$794K	﹤0.01%	2812
2020 Q3	$8.21M	Buy	505,230 +26,001	+5%	+$426K	﹤0.01%	2544
2020 Q2	$7.2M	Buy	479,229 +459,206	+2,293%	+$6.2M	﹤0.01%	2581
2020 Q1	$145K	Sell	20,023 -1,457	-7%	-$11.4K	﹤0.01%	3595
2019 Q4	$128K	Sell	21,480 -320	-1%	-$1.65K	﹤0.01%	3668
2019 Q3	$92K	Buy	+21,800	New	+$81.6K	﹤0.01%	3678

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

State Street's CGEN Position: Q2 2026 in Review

State Street increased its Compugen (CGEN) stake by 0.07% in Q2 2026, buying an estimated $757 and bringing the position to 415,668 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #3481.

State Street first reported a position in CGEN in Q3 2019 and has held it in 28 quarters since. The position peaked at $8.21M in Q3 2020. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

State Street held 415,668 shares of Compugen worth $890K as of Q2 2026.
State Street bought 302 Compugen shares in Q2 2026, an estimated $757.
Compugen made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3481 holding.
State Street first reported a position in Compugen in Q3 2019 and has held it in 28 quarters since.
State Street's Compugen position peaked at $8.21M in Q3 2020.
82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.